The Camp Lejeune lawsuit represents one of the largest toxic-exposure compensation efforts in U.S. history. Under the Camp Lejeune Justice Act of 2022, individuals who lived or worked at Marine Corps Base Camp Lejeune in North Carolina between August 1, 1953, and December 31, 1987, and later developed certain illnesses may seek compensation from the United States for harm linked to contaminated drinking water.
As of mid-2026, the administrative claims process and related federal litigation remain active. More than 400,000 administrative claims have been filed with the Department of the Navy. Settlement offers under the government’s Elective Option program now exceed $968 million, with more than $801 million already paid to claimants. Approximately 3,700 federal lawsuits are pending in the U.S. District Court for the Eastern District of North Carolina. No case has yet produced a trial verdict. The filing window for new claims closed on August 10, 2024.
This article examines the background of the contamination, the legal framework established by Congress, the current status of claims and settlements, who is affected, and what developments to monitor. It is intended for informational purposes only and does not constitute legal advice.
Background & Legal Context
Marine Corps Base Camp Lejeune was established in 1942. For decades, two of its primary water-distribution systems, Hadnot Point and Tarawa Terrace, supplied drinking water contaminated with volatile organic compounds. The principal contaminants included trichloroethylene (TCE), a solvent used in degreasing, and tetrachloroethylene (PCE, also known as perchloroethylene), a dry-cleaning solvent. Additional chemicals such as vinyl chloride, benzene, and dichloroethylene were also present in varying concentrations.
Contamination at Tarawa Terrace stemmed largely from an off-base dry cleaner. Hadnot Point contamination resulted from multiple on-base sources, including industrial spills, leaking underground storage tanks, waste-disposal sites, and other operational activities. The Agency for Toxic Substances and Disease Registry (ATSDR), part of the U.S. Department of Health and Human Services, has documented that finished drinking water from these systems exceeded current Environmental Protection Agency maximum contaminant levels for extended periods. Modeling by ATSDR indicates contamination at Tarawa Terrace from the late 1950s through early 1987 and at Hadnot Point from the early 1950s through early 1985. Contaminated wells were taken offline in 1985.
For years, service members, their families, and civilian workers who developed cancers, neurological disorders, and other conditions faced significant legal barriers. The Federal Tort Claims Act generally requires claimants to prove negligence, and prior doctrines limited recovery against the federal government for injuries occurring on military bases. Many potential claims were barred by statutes of limitations or the Feres doctrine.
Congress addressed these barriers in the Honoring our Promise to Address Comprehensive Toxics Act of 2022, commonly known as the PACT Act. Section 804 of that legislation is the Camp Lejeune Justice Act (CLJA). The CLJA creates a specific federal cause of action for individuals who were exposed to the contaminated water for at least 30 days and later suffered harm. It applies a causation standard of “at least as likely as not,” which is lower than the traditional tort standard of preponderance of the evidence in some respects. Claims must first be presented administratively to the Department of the Navy. If the Navy denies the claim or fails to act within six months, the claimant may file suit in the Eastern District of North Carolina. The CLJA also imposes attorney-fee caps of 20 percent for administrative settlements and 25 percent for litigated cases, and it bars punitive damages against the United States.
The statute established a two-year filing window that closed on August 10, 2024. All administrative claims had to be submitted by that date. Individuals who met the deadline may still pursue litigation if their administrative claims are denied or remain unresolved.
Key Legal Issues Explained
Several legal concepts define the Camp Lejeune process. Understanding them helps clarify rights, responsibilities, and limitations.
First is the administrative-exhaustion requirement. Claimants must present their claims to the Department of the Navy before suing. This mirrors the Federal Tort Claims Act process and allows the government an opportunity to investigate and resolve claims without court involvement.
Second is the causation standard. Under the CLJA, a claimant must show that the contaminated water was at least as likely as not a cause of the injury. This standard draws on scientific assessments by ATSDR. The agency evaluated evidence linking specific contaminants to particular diseases and classified the strength of that evidence.
Third is the Elective Option program, announced jointly by the Department of Justice and the Department of the Navy in September 2023. The Elective Option offers a streamlined settlement path for claimants with certain qualifying injuries. It uses a grid based on two factors: the tier of the injury (reflecting the strength of ATSDR evidence) and the duration of exposure at Camp Lejeune.
Tier 1 injuries, for which ATSDR found stronger evidence of causation, include kidney cancer, liver cancer, non-Hodgkin lymphoma, leukemias, and bladder cancer. Tier 2 injuries include multiple myeloma, Parkinson’s disease, kidney disease or end-stage renal disease (including stages 4 and 5 chronic kidney disease), and systemic sclerosis or systemic scleroderma.
Settlement amounts under the grid are as follows:
- 30 to 364 days of exposure: $150,000 (Tier 1) or $100,000 (Tier 2)
- 1 to 5 years of exposure: $300,000 (Tier 1) or $250,000 (Tier 2)
- More than 5 years of exposure: $450,000 (Tier 1) or $400,000 (Tier 2)
An additional $100,000 is available if the qualifying injury resulted in death, producing a maximum Elective Option payment of $550,000. The program applies a base-wide exposure approach, meaning presence at Camp Lejeune during the statutory period can satisfy the exposure element even if the claimant was not specifically located in a contaminated housing area. Elective Option payments are not offset by Department of Veterans Affairs disability benefits or Medicare fee-for-service payments, a significant distinction from awards obtained through full litigation.
Claimants who decline an Elective Option offer retain the right to continue with their administrative claim or file suit. Recovery outside the Elective Option requires individualized proof of causation and is subject to offsets for certain government benefits.
Fourth, cases proceed as bench trials rather than jury trials. The Eastern District of North Carolina has ruled that the CLJA does not provide a right to a jury, and the U.S. Supreme Court declined to review that determination. Legislation has been introduced in Congress that would restore jury-trial rights, but it has not advanced to enactment.
Finally, discovery and expert evidence play central roles in the litigated cases. Parties have exchanged extensive scientific and medical expert reports addressing water modeling, general causation, specific causation, and damages. Recent court orders have clarified the screening of expert testimony and the application of statutory offsets for benefits paid through programs administered by the Secretary of Veterans Affairs, Medicare, and Medicaid.
Latest Developments or Case Status
As of July 2026, the Camp Lejeune claims process operates on two parallel tracks: the administrative claims system managed by the Department of the Navy and the federal litigation in the Eastern District of North Carolina.
The Department of the Navy has received approximately 408,000 to 410,000 de-duplicated administrative claims. The filing deadline has passed, so the focus is entirely on processing existing claims. The Navy’s Camp Lejeune Claims Unit reviews documentation, verifies presence on base, and evaluates qualifying injuries. A claims-management portal allows claimants and their representatives to track status, upload documents, and communicate with the claims unit.
Settlement activity under the Elective Option has accelerated. According to the Department of Justice Civil Division, as of July 17, 2026, settlement offers exceed $968 million and actual payouts exceed $801 million. Earlier figures from May and June 2026 showed offers above $876 million to $907 million and payments above $665 million to $723 million, illustrating steady progress. Even so, the number of resolved claims remains well under 1 percent of the total administrative docket. Only a relatively small subset of claims currently possess the documentation and qualifying injuries needed for prompt Elective Option consideration. Documentation gaps, particularly proof of presence and medical records establishing diagnosis timing, continue to slow processing for many claimants.
In the federal court, roughly 3,700 to 3,756 lawsuits have been filed. After voluntary and involuntary dismissals, approximately 3,590 cases remain pending. The cases are assigned among four judges. The court has organized the litigation into tracks, with Track 1 focusing on five primary illnesses: bladder cancer, kidney cancer, leukemia, non-Hodgkin lymphoma, and Parkinson’s disease. Bellwether or test cases from these categories are progressing through discovery and pretrial proceedings. Expert discovery on scientific issues is largely complete. Fact discovery and damages-related discovery have also advanced substantially.
No Camp Lejeune case has reached a final verdict. Trial dates for the first group of Track 1 cases have been discussed for later in 2026, though schedules have shifted previously. The outcomes of these early trials are expected to influence broader settlement discussions by providing benchmarks for case valuation.
Recent court orders issued in June 2026 addressed important procedural matters. One ruling limited the government’s ability to apply automatic offsets for certain federal benefits unless it can prove those benefits specifically related to conditions caused by the Camp Lejeune water. Another order excluded late-submitted expert reports from a government medical expert. These decisions refine the rules under which cases will be tried but do not resolve the underlying claims.
Joint status reports continue to be filed regularly with the court, providing updates on claim volumes, discovery progress, and settlement activity. Settlement masters have been involved in facilitating discussions, although they lack authority to compel resolution.
Who Is Affected & Potential Impact
The Camp Lejeune population includes Marines, sailors, civilian employees, and family members who lived or worked on the base during the relevant period. ATSDR and related studies have associated the contaminated water with elevated risks of certain cancers, Parkinson’s disease, kidney disease, and other conditions. The CLJA extends eligibility to any person who was present for at least 30 days, not solely to veterans.
For individuals and families, the primary impact is access to compensation that was previously unavailable. Elective Option payments provide relatively prompt, predictable awards for those who qualify, without the need for extensive expert battles over causation. For others, the litigation path offers the possibility of individualized damages awards that may exceed Elective Option amounts, particularly in cases involving severe or fatal illness, substantial medical costs, or lost earnings. Those awards, however, carry greater uncertainty, longer timelines, and potential offsets.
The federal government faces significant financial exposure. The Congressional Budget Office has estimated lifetime program costs in the range of $21 billion. Processing hundreds of thousands of claims requires substantial administrative resources within the Department of the Navy and the Department of Justice. The volume also places demands on the Eastern District of North Carolina, one of the busier federal districts.
Institutions and professionals monitoring the litigation include veterans’ service organizations, mass-tort practitioners, and government claims administrators. The outcomes will shape how future large-scale toxic-tort claims against the United States are structured, particularly regarding administrative settlement grids, causation standards, and trial procedures.
Claimants who accepted Elective Option offers receive payment relatively quickly once documentation is complete, typically within 60 days. Those pursuing litigation must navigate discovery, potential motions practice, and eventual bench trials. Many claimants are still gathering records or waiting for administrative decisions before deciding whether to file suit.
What This Means Going Forward
The Camp Lejeune litigation occupies a pivotal stage. Administrative settlement volume is increasing, yet the vast majority of claims remain unresolved. Bellwether trials, if they proceed on schedule, will supply concrete data points on how federal judges evaluate causation evidence, exposure proof, and damages under the CLJA standard. Those results are likely to inform both individual case valuations and any broader resolution frameworks the parties may develop.
Documentation remains the practical bottleneck. Claimants who can promptly supply service records, employment records, housing documentation, and medical records establishing diagnosis dates and conditions stand the best chance of moving forward in either the Elective Option or litigation track. The Navy has indicated it will accept personal records to establish the 30-day presence requirement in order to reduce delays associated with official service-record retrieval.
Broader policy questions persist. Legislation that would restore jury trials or adjust other procedural aspects has been introduced but has not advanced. The interplay between CLJA awards and existing veterans’ benefits programs continues to generate legal disputes that courts are resolving case by case.
For the public and the legal community, the Camp Lejeune experience illustrates both the power and the challenges of creating specialized statutory remedies for historical government-related harm. It demonstrates that large-scale administrative claims programs can deliver meaningful compensation to some claimants relatively efficiently, while still requiring robust litigation infrastructure for cases that fall outside streamlined criteria or involve contested causation.
Readers following the matter should monitor Department of Justice and Department of the Navy public statements on settlement totals, joint status reports filed in the Eastern District of North Carolina, and any announcements regarding trial schedules or new resolution frameworks. Official sources such as the Navy’s Camp Lejeune claims portal and the Department of Justice Civil Division page remain the most reliable places for current figures and guidance.
Conclusion
The Camp Lejeune lawsuit continues to evolve nearly four years after enactment of the Camp Lejeune Justice Act. Hundreds of thousands of administrative claims remain under review, settlement payments under the Elective Option have surpassed $800 million, and federal litigation is progressing toward the first trials. The process reflects a deliberate congressional effort to provide a pathway for compensation where traditional tort remedies had been unavailable, while still requiring claimants to establish presence, injury, and a sufficient causal connection under the statutory standard.
Progress is real yet uneven. Claimants with complete documentation and qualifying injuries under the Elective Option have begun to receive payments. Many others continue to wait for administrative decisions or the results of early trials that will help define the value of remaining claims. The Eastern District of North Carolina, the Department of the Navy, and the Department of Justice remain the central institutions managing this large-scale resolution effort.
Individuals and families affected by the historical water contamination at Camp Lejeune should continue to monitor official updates from the Department of Justice, the Department of the Navy, and the federal court. Accurate information from primary government sources remains essential for understanding both current status and future developments in this significant public-interest litigation.
Frequently Asked Questions
Can I still file a new Camp Lejeune claim in 2026?
No. The statutory filing deadline under the Camp Lejeune Justice Act closed on August 10, 2024. The Department of the Navy is no longer accepting new administrative claims. Individuals who filed timely claims may still pursue litigation if their claims are denied or remain undecided after six months.
What is the current total of Camp Lejeune settlements?
As of July 17, 2026, the Department of Justice reports that Camp Lejeune Justice Act settlement offers exceed $968 million and actual payouts exceed $801 million. These figures primarily reflect Elective Option resolutions. The number of resolved claims remains a small fraction of the overall administrative docket.
What illnesses qualify for the Elective Option?
Tier 1 illnesses are kidney cancer, liver cancer, non-Hodgkin lymphoma, leukemias, and bladder cancer. Tier 2 illnesses are multiple myeloma, Parkinson’s disease, kidney disease or end-stage renal disease (including stages 4 and 5), and systemic sclerosis or systemic scleroderma. Additional requirements include diagnosis timing relative to exposure and the 30-day presence threshold.
Have any Camp Lejeune cases gone to trial?
No case has produced a final verdict as of mid-2026. Track 1 bellwether cases involving the primary illnesses are advancing toward potential trial dates later in 2026. Trials will be conducted as bench trials before federal judges.
Do Elective Option settlements affect VA benefits?
No. Accepting an Elective Option settlement does not reduce Department of Veterans Affairs disability benefits or Medicare fee-for-service payments. Awards obtained outside the Elective Option may be subject to offsets for certain benefits.
How long does the claims process take?
There is no fixed timeline. Elective Option payments can issue within approximately 60 days after acceptance and completion of payment paperwork. Administrative review of non-Elective Option claims and full litigation can take substantially longer, depending on documentation completeness, discovery, and court scheduling.
You May Also Like: JPMorgan Chase Interest Rate Lawsuit Explained for Customers
